The study will be an observational, cross-sectional study of knowledge, understanding, and self-reported behavior among a sample of physicians and patients with recent aflibercept experience in a total of up to five European countries.
Study Type
OBSERVATIONAL
Enrollment
716
Survey to measure physician awareness and understanding of the key messages in the educational materials: the prescriber guide and video.
Survey to measure patient awareness and understanding of the key messages in the educational materials: the patient booklet "Your guide to EYLEA," patient information leaflet, and audio CD.
Unnamed facility
Many Locations, France
Unnamed facility
Many Locations, Germany
Unnamed facility
Many Locations, Italy
Unnamed facility
Many Locations, Spain
Unnamed facility
Many Locations, United Kingdom
The proportion of physicians with accurate knowledge and understanding of key safety information (identified risks and prescribing behaviors) contained in the Eylea educational materials as assessed by a study specific questionnaire.
Time frame: Up to 2 years
The proportion of patients with accurate knowledge and understanding of key safety information (identified risks and guidelines) contained in the Eylea educational materials as assessed by a study specific interviewer administered questionnaire.
Time frame: Up to 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.